Exclusion criteria:~1. Clinical, laboratory or neuroimaging findings consistent with:~* other primary
degenerative dementia, (dementia with Lewy bodies, frontotemporal dementia, Huntington's disease,
Jacob-Creutzfeld Disease, Down's syndrome, etc.)~* other neurodegenerative condition (Parkinson's Disease,
amyotrophic lateral sclerosis, etc.)~* cerebrovascular Disease (major infarct, one strategic or multiple
lacunar infarcts, extensive white matter lesions > one quarter of the total white matter)~* other central
nervous system diseases (severe head trauma, tumors, subdural haematoma or other space occupying processes,
etc.)~* seizure disorder~* other infectious, metabolic or systemic diseases affecting central nervous system
(syphilis, present hypothyroidism, present vitamin B12 or folate deficiency confirmed by current analyses not
older than 1 month, serum electrolytes out of normal range, juvenile onset diabetes mellitus, etc.) 2. A
current DSM-IV diagnosis of active major depression, schizophrenia or bipolar disorder.~ 3. Chronic daily drug
intake for a time period of ≥ 14 days or expected for ≥ 14 days: ~* antidepressants, benzodiazepines,
neuroleptics, major sedatives or other anti-inflammatory drugs including acetylic salicylic acid defined~*
antiepileptics~* anticholinergics~* nootropics (including Ginkgo)~* centrally active anti-hypertensive drugs
(clonidine, alpha-methyl dopa, guanidine, guanfacine,)~* opioid containing analgesics~* anti-inflammatory
agents, cortico-steroids or immunosuppressants~* Cimetidin as gastroprotective drug 4. Severe thrombocytopenia
defined as platelet counts <100.000 per mm3. 5. Coagulation disorders
